Risk versus Benefit of Chemoprevention among Raloxifene and Tamoxifen Users with a Family History of Breast Cancer
Chelsea Anderson(University of North Carolina at Chapel Hill), Dale P. Sandler(University of North Carolina at Chapel Hill), Melissa House(Westat (United States)), Hazel B. Nichols(University of North Carolina at Chapel Hill)
Cited by 9
Related Papers
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium
|Journal of Clinical Oncology|2016|517
Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women
|JAMA Oncology|2018|369
Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies
|CINECA IRIS Institutial research information system (University of Pisa)|2018|204
Pesticide exposure and amyotrophic lateral sclerosis
|NeuroToxicology|2012|164